TLR1 protein drives immune response to certain food-borne illness in mice

Keck School of Medicine of USC researchers identify potential target for improving vaccinations that protect against infections of the lung and gut

2012-07-11

(Press-News.org) A naturally occurring protein called TLR1 plays a critical role in protecting the body from illnesses caused by eating undercooked pork or drinking contaminated water, according to new research from the University of Southern California (USC).

The discovery may help create more effective oral vaccines for infections of the respiratory and gastrointestinal systems and already has launched an examination of how TLR1 is linked to inflammatory bowel disease, says R. William DePaolo, assistant professor of molecular microbiology and immunology at the Keck School of Medicine of USC and the study's lead investigator.

"It's not clear what drives the body's immune response," DePaolo said. "This paper identifies a receptor that is important in driving a mucosal immune response against Yersinia enterocolitica, bacteria like Salmonella and E. coli that can cause food poisoning. Although the receptor's role against other bacteria is still unknown, our research emphasizes that the way the body initiates an immune response depends on the pathogen and the route of infection."

The study, "A specific role for TLR1 in protective TH17 immunity during mucosal infection," is scheduled to appear in the July 30 edition of The Journal of Experimental Medicine, a leading biomedical journal published by the Rockefeller University Press. The manuscript is now available on the journal's website.

DePaolo's team compared the immune responses of mice bred with and without TLR1 when infected with Y. enterocolitica by mouth and by blood. They found that TLR1 played a significant role in controlling mucosal infection (by mouth) but not systemic infection (by blood), initiating the creation of antibodies that specifically fight against oral infections.

"Now that we have identified the receptor's role, the next step is to determine how we can manipulate that receptor to enhance vaccine development," DePaolo said. "We also are studying the receptor in different models of mucosal inflammation including inflammatory bowel disease and colitis-associated cancers. The idea is to take a personalized approach to medicine and use genetic profiling to better treat or manage disease."

###The research was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (5K01DK082725-05) and Crohn's and Colitis Foundation of America (Senior Research Award 2831).

ELSE PRESS RELEASES FROM THIS DATE:

'We can still save our reefs:' Coral scientist

2012-07-11

John Pandolfi keeps his optimism alive despite the grim scientific evidence he confronts daily that the world's coral reefs are in a lot of trouble – along with 81 nations and 500 million people who depend on them. The world-renowned coral scientist from the ARC Centre of Excellence for Coral Reef Studies and University of Queensland has traced the story of the world's reefs over more than 50 million years and is deciphering delicate signals from the past to reveal what doomed them in previous extinctions – and how this compares with today. This knowledge is priceless ...

Cancer Cell article shows first evidence for targeting of Pol I as new approach to cancer therapy

2012-07-11

San Diego, July 10, 2012 – Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells. The researchers repeated these studies with in vivo ...

Investigating the impact of treatment on new HIV infections: New PLoS collection

2012-07-11

Is it possible to cut HIV transmission by using antiretroviral treatment? A collection of new articles published in the open-access journal PLoS Medicine, in conjunction with the HIV Modelling Consortium, addresses this pressing question. The PLoS Medicine articles provide insights into the feasibility of interventions, their potential epidemiological impact and affordability, and recent scientific observational studies and community trials, which will support evidence-based decision-making on the use of antiretroviral treatment to prevent HIV transmission. The background ...

Despite benefit, hospitals not always alerted of incoming stroke patients

2012-07-11

Treatment is delivered faster when emergency medical services (EMS) personnel notify hospitals a possible stroke patient is en route, yet pre-notification doesn't occur nearly one-third of the time. That's according to two separate Get With The Guidelines®– Stroke program studies published in American Heart Association journals. The American Heart Association/American Stroke Association recommends EMS notify hospitals of incoming stroke patients to allow stroke teams to prepare for prompt evaluation and treatment. Quick response is vital for stroke patients, particularly ...

Tiny magnetic particles may help assess heart treatments

2012-07-11

Tiny magnetic particles may help doctors track cells in the body to better determine if treatments work, according to research reported in Circulation: Cardiovascular Imaging, an American Heart Association journal. Researchers showed that injecting immune cells containing magnetic particles into the bloodstream was safe and did not interfere with cell function. Magnetic resonance imaging (MRI) scans can then track the cells moving through the body. "This could change how we assess new treatments affecting inflammation and the outcome of a heart attack or heart failure," ...

Study examines risk of poor birth outcomes following H1N1 vaccination

2012-07-11

CHICAGO – In studies examining the risk of adverse outcomes after receipt of the influenza A(H1N1) vaccine, infants exposed to the vaccine in utero did not have a significantly increased risk of major birth defects, preterm birth, or fetal growth restriction; while in another, study researchers found a small increased risk in adults of the nervous system disorder, Guillain-Barre syndrome, during the 4 to 8 weeks after vaccination, according to 2 studies in the July 11 issue of JAMA. In the first study, Björn Pasternak, M.D., Ph.D., of the Statens Serum Institut, Copenhagen, ...

H1N1 vaccine associated with small but significant risk of Guillain-Barre syndrome

2012-07-11

Guillain-Barre syndrome (GBS) is usually characterized by rapidly developing motor weakness and areflexia (the absence of reflexes). "The disease is thought to be autoimmune and triggered by a stimulus of external origin. In 1976-1977, an unusually high rate of GBS was identified in the United States following the administration of inactivated 'swine' influenza A(H1N1) vaccines. In 2003, the Institute of Medicine (IOM) concluded that the evidence favored acceptance of a causal relationship between the 1976 swine influenza vaccines and GBS in adults. Studies of seasonal ...

Administration of regulating agent prior to CABG surgery does not appear to improve outcomes

2012-07-11

Among intermediate- to high-risk patients undergoing coronary artery bypass graft surgery, administration of the agent acadesine to regulate adenosine (a naturally occurring chemical that dilates blood flow and can improve coronary blood flow and perfusion) did not reduce all-cause death, nonfatal stroke, or need for mechanical support for ventricular dysfunction, for approximately a month after surgery, according to a study in the July 11 issue of JAMA. "Despite improvements in myocardial protection and perioperative care, the risk of death is still substantial in the ...

Receiving chemotherapy following removal of type of cancer near pancreas may improve survival

2012-07-11

Patients who had surgery for periampullary cancer (a variety of types of cancer that are located in and near the head of the pancreas, including an area called the ampulla where the bile duct joins up with the pancreatic duct to empty their secretions into the upper small intestine) and received chemotherapy had a statistically significant survival benefit, compared to patients who did not receive chemotherapy, after adjusting for prognostic variables, according to a study in the July 11 issue of JAMA. Periampullary carcinomas arise from the head of the pancreas. "The ...

Evidence for emergency obstetric referral interventions in developing countries is limited

2012-07-11

In this week's PLoS Medicine, Julia Hussein from the University of Aberdeen in Scotland and colleagues assess the evidence for the effectiveness of interventions that aim to help pregnant women reach health facilities during an emergency in developing country settings. In a systematic review of the literature they found that the level of evidence for emergency obstetric referral interventions was poor and that limitations in the design of individual studies made determining the effect of referral interventions on outcomes difficult. The authors note, "[d]espite the wealth ...

TLR1 protein drives immune response to certain food-borne illness in mice

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: